The world health report

Chapter 5


Bibliography

  • Mason J, Drummond M. Reporting guidelines for economic studies. Health Economics 1995; 4(2):85-94.
  • Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
  • Murray CJ, Evans DB, Acharya A, Baltussen RM. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Economics 2000; 9((3)): 235-51.
  • Murray CJ, Frenk J. A framework for assessing the performance of health systems. Bulletin of the World Health Organization 2000; 78((6)): 717-31.
  • World Health. The World Health Report 2000: Health systems: Improving performance.. Geneva: World Health Organization; 2000.
  • Krummel DA, Humphries D, Tessaro I. Focus groups on cardiovascular health in rural women: implications for practice. Journal of Nutrition Education and Behavior 2002; 34((1)): 38-46.
  • Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychology 2002; 21((1)): 3-15.
  • West R. Theories of addiction. Addiction 2001; 96((1)): 3-13.
  • Torgerson DJ, Raftery J. Economic notes. British Medical Journal 1999; 319((7214)): 914-5.
  • Okrah J, Traore C, Pale A, Sommerfeld J, Muller O. Community factors associated with malaria prevention by mosquito nets: an exploratory study in rural Burkina Faso. Tropical Medicine & International Health 2002; 7((3)): 240-8.
  • Collins R, Peto R, Armitage J. The MRC/BHF Heart Protection Study: preliminary results. International Journal of Clinical Practice 2002; 56((1)): 53-6.
  • Marshall T, Rouse A. Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study. British Medical Journal 2002; 325((7357)): 197.
  • Rose G. Sick individuals and sick populations. International Journal of Epidemiology 2001; 30((3)): 427-32.
  • Jha P, Chaloupka FJ. The economics of global tobacco control. British Medical Journal 2000; 321((7257)): 358-61.
  • Joossens L, Raw M. Smuggling and cross border shopping of tobacco in Europe. British Medical Journal 1995; 310((6991)): 1393-7.
  • Chang M, Hahn RA, Teutsch SM, Hutwagner LC. Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992. Journal of Clinical Epidemiology 2001; 54((6)): 634-44.
  • Baltussen RMPM, Hutubessy RC, Evans DB, Murray CJL. Uncertainty in cost-effectiveness analysis. International Journal of Technology Assessment in Health Care 2002; 18((1)): 112-9.
  • Baltussen RM, Adam T, Tan Torres, Hutubessy RC, Acharya A, Evans DB, Murray CJL. Generalized cost-effectiveness analysis: a guide.. Geneva: World Health Organization, Global Programme on Evidence for Health Policy; 2002.
  • Hutubessy RCW, Baltussen RMPM, Evans DB, Barendregt JJ, Murray CJL. Stochastic league tables: communicating cost-effectiveness results to decision makers. Health Economics 2002; 10((5)): 473-7.
  • Gravelle H, Smith D. Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Economics 2001; 10((7)): 587-99.
  • Tasset A, Nguyen VH, Wood S, Amazian K. Discounting: technical issues in economic evaluations of vaccination. Vaccine 1999; 17 Suppl 3:S75-S80.
  • Nissinen A, Berrios X, Puska P. Community-based noncommunicable disease interventions: lessons from developed countries for developing ones. Bulletin of the World Health Organization 2001; 79((10)): 963-70.
  • WHO Commission. Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. Geneva: World Health Organization; 2001.
  • World Health. Primary health care: report of the International Conference on Primary Health Care, Alma-Ata. Geneva: World Health Organization; 1978.
  • Walsh JA, Warren KS. Selective primary health care: an interim strategy for disease control in developing countries. New England Journal of Medicine 1979; 301((18)): 967-74.
  • Warren KS. The evolution of selective primary health care. Social Science and Medicine 1988; 26((9)): 891-8.
  • Claeson M, Waldman RJ. The evolution of child health programmes in developing countries: from targeting diseases to targeting people. Bulletin of the World Health Organization 2000; 78((10)): 1234-45.
  • GAVI. Immunize every child: GAVI strategy for sustainable immunization services. February 2000. Working paper of the Global Alliance for Vaccines and Immunization, 2000 (unpublished document available on http://www.vaccinealliance.org).
  • Caulfield L, Huffman S, Piwoz E. Interventions to improve intake of complementary foods by infants 6 to 12 months of age in developing countries: impact on growth and on the prevalence of malnutrition and potential contribution to child survival. Food and Nutrition Bulletin 1999; 20: 183-99.
  • UNICEF/UNU/WHO/MI. Preventing Iron Deficiency in Women and Children. Technical Consensus on Key Issues.. Technical Workshop, UNICEF, New York, 7-9 October 1998. Boston: International Nutrition Foundation and Micronutrient Initiative; 1999.
  • Stoltzfus R, Dreyfuss M. Guidelines for the use of iron supplements to prevent and treat iron deficiency anaemia. Washington, D.C.: The International Nutritional Anaemia Consultative Group (INACG/WHO/UNICEF); 1998.
  • Galloway R, McGuire J. Social Science and Medicine. 1994; 39(3):381-90.
  • Mora JO, Dary O, Chinchilla D, Arroyave G. Vitamin A sugar fortification in Central America. Experience and lessons learned. Arlington, VA: MOST, The USAID Micronutrient Program; 2000.
  • Victora CG, Olinto MT, Barros FC, Nobre LC. Health Policy and Planning. 1996; 11(2):132-41.
  • Miller P, Hirschhorn N. The effect of a national control of diarrheal diseases program on mortality: the case of Egypt. Social Science and Medicine 1995; 40(10):S1-S30.
  • Sazawal S, Black RE. Meta-analysis of intervention trials on case-management of pneumonia in community settings. Lancet 1992; 340((8818)): 528-33.
  • World Health. Innovative care for chronic conditions: building bloks for action. Geneva, World Health Organization, 2002 (unpublished document WHO/MNC/CCH/02.01).
  • Puska P. Development of public policy on the prevention and control of elevated blood cholesterol. Cardiovascular Risk Factors 1996; 6((4)): 203-10.
  • European Heart. Food, nutrition and cardiovascular disease prevention in the European region: challenges for the new millenium. Brussels: 2002.
  • Utting P. Regulating business via multistakeholder initiatives: a preliminary assessment. Voluntary approaches to corporate responsibility 2002;
  • Lawes C, Feigin V, Rodgers A. Estimating reductions in blood pressure following reductions in salt intake by age, sex and WHO region. Auckland: Clinical Trials Research Unit, University of Auckland; 2002.
  • Tosteson AN, Weinstein MC, Hunink MG, Mittleman MA, Williams LW, Goldman PA. Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. Circulation 1997; 95((1)): 24-30.
  • World Health. eduction of cardiovascular burden through cost-effective integrated management of cardiovascular risk: addressing hypertension, smoking cessation and diabetes. Geneva, World Health Organization, 2002 (unpublished document NMH meeting report, 9-12 July 2002).
  • Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. British Medical Journal 2002; 324((7353)): 1570-6.
  • Miller MR, Pollard CM, Coli T. Australia and New Zealand Journal of Public Health. 1997; 21: 638-42.
  • The health of New Zealanders 1996/7. Wellington: New Zealand Ministry of Health; 1999.
  • National nutrition survey. Canberra: Australian Bureau of Statistics; 1996.
  • Mathers C, Vos T, Stevenson C. 1999. The burden of disease and injury in Australia 1999;
  • Vos T, Begg S. The Victorian Burden of Disease Study: mortality.. Melbourne: Public Health and Development Division, Victorian Government Department of Human Services; 1999.
  • Vos T, Begg S. The Victorian Burden of Disease Study: morbidity. Melbourne: Public Health and Development Division, Victorian Government Department of Human Services; 1999.
  • Carter R, Stone C, Vos T, Hocking J, Mihalopoulos C, Peacock S, et al. Trial of Program Budgeting and Marginal Analysis (PBMA) to assist cancer control planning in Australia. Canberra: Commonwealth Department of Health and Aged Care; 2000.
  • Dixon H, Borland R, Segan C, Stafford H, Sindall C. Public reaction to Victorian "2 fruit `n' 5 veg every day" campaign and reported consumption of fruit and vegetables. Preventive Medicine 1998; 27: 572-82.
  • Mathers C, Stevenson C, Carter R, Penm R. Disease costing methodology used in the Disease Costs and Impact Study 1993-94. Canberra: Australian Institute of Health and Welfare; 1998. Health Expenditure Series No. 3, AIHW Cat. No. HWE 7.
  • Mathers C, Penm R, Sanson-Fisher R, Carter R, Campbell E. Health system costs of cancer in Australia 1993-94. Canberra: Australian Institute of Health and Welfare; 1998.
  • Mathers C, Penm R. Health system costs of cardiovascular costs and diabetes in Australia 1993-94. Canberra: Australian Institute of Health and Welfare; 1999.
  • UNAIDS. Report on the global HIV/AIDS epidemic June 2000. Geneva: UNAIDS; 2000.
  • Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD. Lancet. 2002; 360(9326):73-7.
  • Goldstein S, Scheepers E. Soul City 4 impact evaluation: AIDS. www.soulcity.org.za. 2000.
  • Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000; 356((9224)): 113-21.
  • Nyblade LC, Menken J, Wawer MJ, Sewankambo NK, Serwadda D, Makumbi F. Population-based HIV testing and counseling in rural Uganda: participation and risk characteristics. Journal of Acquired Immune Deficiency Syndromes 2001; 28((5)): 463-70.
  • Anderson JE, Carey JW, Taveras S. HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996. American Journal of Public Health 2000; 90((7)): 1089-95.
  • Stanton BF, Li X, Kahihuata J, Fitzgerald AM, Neumbo S, Kanduuombe G. Increased protected sex and abstinence among Namibian youth following a HIV risk-reduction intervention: a randomized, longitudinal study. AIDS 1998; 12((18)): 2473-80.
  • Shuey DA, Babishangire BB, Omiat S, Bagarukayo H. Increased sexual abstinence among in-school adolescents as a result of school health education in Soroti district, Uganda. Health Education Research 1999; 14((3)): 411-9.
  • Ngugi EN, Wilson D, Sebstad J, Plummer FA, Moses S. Focused peer-mediated educational programs among female sex workers to reduce sexually transmitted disease and human immunodeficiency virus transmission in Kenya and Zimbabwe. Journal of Infectious Diseases 1996; 174 Suppl 2:S240-S247.
  • Levine WC, Revollo R, Kaune V, Vega J, Tinajeros F, Garnica M. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS 1998; 12((14)): 1899-906.
  • Morisky D, Tiglao TV, Baltazar J, Detels R, Sneed C. The effects of peer counseling on STD risk-behaviors among heterosexual males in the Philippines. XIII International AIDS Conference, abstract WeOrD589, 2000 (unpublished document ).
  • Njagi E, Kimani J, Plummer FA, Ndinya-Achola JO, Bwayo JJ, Ngugi EN. Long-term impact of community peer interventions on condom use and STI incidence among sex workers in Nairobi. Int Conf AIDS, 12:691 abstract no. 33515, 1998 (unpublished document ).
  • Steen R, Vuylsteke B, DeCoito T, Ralepeli S, Fehler G, Conley J. Evidence of declining STD prevalence in a South African mining community following a core-group intervention. Sexually Transmitted Diseases 2000; 27((1)): 1-8.
  • Kahn JG, Kegeles SM, Hays R, Beltzer N. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men. Journal of Acquired Immune Deficiency Syndromes 2001; 27((5)): 482-91.
  • Mota M, Parker R, Lorenco L, Almeida V, Pimenta C, Fernandes MEL. Sexual behavior and behavior change among men who have sex with men in Brazil, 1989-1994. Third USAID HIV/AIDS Prevention Conference, abstract no.A-39, 1995 (unpublished document ).
  • Haque A, Ahmed S. Community based risks reduction approach among MSM: Bandhu Social Welfare Society : HIV/AIDS/STD prevention program. XIII International AIDS Conference, abstract no. WePeD4745, 2000 (unpublished document ).
  • Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA : the Journal of the American Medical Association 2001; 285((10)): 1308-15.
  • Pezzotti P, Napoli PA, Acciai S, Boros S, Urciuoli R, Lazzeri V. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. AIDS 1999; 13((2)): 249-55.
  • McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. AIDS 1999; 13((13)): 1687-95.
  • Stover J, Bollinger L, Cooper-Arnold K. Goals model: for estimating the effects of resource allocation decisions on the achievement of goals of the HIV/AIDS strategic plan. Glastonbury: The Futures Group International; 2001.
  • World Health. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization; 1998.
  • Chaloupka FJ, Hu TW, Warner KE, Jacobs R, Yurekli A. The taxation of tobacco products. Jha P, Chaloupka FJ, editors. Tobacco control in developing countries. Oxford: Oxford University Press; 2000.
  • Tobacco control country profiles. Atlanta, GA: American Cancer Society; 2000.
  • Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. British Medical Journal 2002; 325((7357)): 188.
  • World Health. Member states need to take action against tobacco advertising. Press Release WHO/47. Geneva: World Health Organization; 2001.
  • Saffer H, Chaloupka F. The effect of tobacco advertising bans on tobacco consumption. Journal of Health Economics 2000; 19((6)): 1117-37.
  • Kenkel D, Chen L. Consumer information and tobacco use. Jha P, Chaloupka FJ, editors. Tobacco control in developing countries. Oxford: Oxford University Press; 2000.
  • Global burden of injuries. Geneva: World Health Organization; 1999.
  • Muller A. Evaluation of the costs and benefits of motorcycle helmet laws. American Journal of Public Health 1980; 70((6)): 586-92.
  • Fuchs VR. Motor accident mortality and compulsory inspection of vehicles. The health economy 1986;
  • Rice DP, MacKenzie EJ, Jones AS, Kaufman SR, DeLissovoy GV, Max W, et al. Cost of injury in the United States: a report to Congress. San Francisco (CA): Institute for Health and Aging, University of California; and Injury Prevention Center, The Johns Hopkins University; 1989.
  • Graham JD, Thompson KM, Goldie SJ, Segui-Gomez M, Weinstein MC. Cost-effectiveness of air bags by seating position. JAMA 1997; 278((17)): 1418-25.
  • Mannering F, Winston C. Recent automobile occupant safety proposals in blind intersection: policy and the automobile industry. Washington (DC): Brookings Institution; 1987.
  • Kamerud DB. Benefits and costs of the 55 mph speed limit: new estimates and their implications. Journal of Policy Analysis and Management 1988; 7((2)): 341-52.